Their INKT share price targets range from $3.00 to $10.00. On average, they anticipate the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 537.3% from the stock's current price. View analysts price targets for INKT or view top-rated stocks among Wall Street analysts.
Should you buy Mik Therapeutics (iNKT) stock?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MiNK Therapeutics in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" INKT shares. View INKT analyst ratings or view top-rated stocks. What is MiNK Therapeutics' stock price target for 2024?
What are mink Therapeutics' stock price targets?
3 brokers have issued 12-month price objectives for MiNK Therapeutics' stock. Their INKT share price targets range from $3.00 to $10.00. On average, they anticipate the company's stock price to reach $6.50 in the next twelve months.
